| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/14/2002 | US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion. |
| 03/14/2002 | US20020032311 Interleukin-19 |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032167 Increasing dwell time of fluid in a targeted area, administration of vascular permeablizing agent, and administration of a viral vector containing a gene expression cassette of interest |
| 03/14/2002 | US20020032162 For inducing immune responses in a vertebrate against Mycobacterial epitopes |
| 03/14/2002 | US20020032110 Array centrifuge |
| 03/14/2002 | US20020031831 Plasmid for use in vaccination and gene therapy |
| 03/14/2002 | US20020031829 Arrayed collection of genomic clones |
| 03/14/2002 | US20020031826 Glucan-containing compositions and paper |
| 03/14/2002 | US20020031823 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
| 03/14/2002 | US20020031816 Method of inhibition of human glycogen phosphorylase |
| 03/14/2002 | US20020031815 46619, a novel human beta-ketoacyl synthase and uses thereof |
| 03/14/2002 | US20020031813 Electric-field-assisted fluidic assembly of inorganic and organic materials, molecules and like small things including living cells |
| 03/14/2002 | US20020031810 Nucleotide sequences coding for the lipA gene |
| 03/14/2002 | US20020031809 Nucleotide sequences coding for the lipB gene |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | US20020031801 Nucleotide sequences coding enzymatic polypeptide for use in modulating immune response and cellular differentiation; for use in the diagnosis and treatment of blood, immune response, cell differentiation and proliferation defects |
| 03/14/2002 | US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | US20020031799 Mammalian coagulation protein; for use in treatment of blood disorders |
| 03/14/2002 | US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031790 Reducing inaccuracy in protein activity; obtain target particles, incubate with probes, monitor and detect binding activity of particles |
| 03/14/2002 | US20020031785 Splice variants of brca1 and brca2 |
| 03/14/2002 | US20020031779 Rapid-screen cDNA library panels |
| 03/14/2002 | US20020031778 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 03/14/2002 | US20020031775 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 03/14/2002 | US20020031774 Process for aligning macromolecules by passage of a meniscus and applications |
| 03/14/2002 | US20020031771 Nucleic acid profile of preferential sample; obtain nucleotide sequences from sample, sequence, compare sequence with those in sequence libraries, detect homology |
| 03/14/2002 | US20020031765 Oligonucleotides for identifying precursors of amidated polypeptide hormones |
| 03/14/2002 | US20020031764 Generating preferential nucleotide sequences; obtain nucleic acid mix, incubate with polymerase, amplify sequences, recover preferential sequences |
| 03/14/2002 | US20020031763 Complexing |
| 03/14/2002 | US20020031762 Genetic engineering |
| 03/14/2002 | US20020031760 Nucleotide sequences for use in the detection of preferential microorganism |
| 03/14/2002 | US20020031759 Diagnosing pancreatic defect in humans; obtain organelle sample, detect preferential organelle, monitor sample for organelle defect, diagnose pancreatic defect |
| 03/14/2002 | US20020031527 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 03/14/2002 | US20020031521 Method of DNA transfer |
| 03/14/2002 | US20020031520 Prevention and treatment of hepatocellular cancer |
| 03/14/2002 | US20020031502 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
| 03/14/2002 | US20020031501 Cardiomyocytes for heart muscles damaged in heart attacks |
| 03/14/2002 | US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/14/2002 | US20020031496 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/14/2002 | US20020031494 Nucleic acids for reducing carbohydrate epitopes |
| 03/14/2002 | US20020031493 Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf) |
| 03/14/2002 | US20020029969 Substrate with many channels filled with a homogeneous separation matrix which acts as an obstacle to the electrophoretic migration of the charged molecules, using a series of micro-electrodes to move a sample |
| 03/14/2002 | DE10109690A1 Neue für das metY-Gen kodierende Nukleotidsequenzen New coding for the metY gene nucleotide sequences |
| 03/14/2002 | DE10108841A1 Neue für das citB-Gen kodierende Nukleotidsequenzen New coding for the citB gene nucleotide sequences |
| 03/14/2002 | DE10108463A1 Neue für das citA-Gen kodierende Nukleotidsequenzen New coding for the citA gene nucleotide sequences |
| 03/14/2002 | DE10044027A1 New nucleic acid encoding preprotein of mistletoe lectin, useful as diagnostic and therapeutic agents, also encodes polypeptide |
| 03/14/2002 | DE10043902A1 New nucleic acid for the barley homeobox gene JuBel2, useful for altering phenotype of plants, e.g. increased branching for improved crop yields |
| 03/14/2002 | DE10043702A1 New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
| 03/14/2002 | DE10043331A1 New polynucleotide from coryneform bacteria, useful when overexpressed for increasing fermentative amino acid production, encodes sigma factor D |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |
| 03/14/2002 | DE10042742A1 Neue für das lipA-Gen kodierende Nukleotidsequenzen New coding for the lipA gene nucleotide sequences |
| 03/14/2002 | DE10042739A1 Neue für das lipB-Gen kodierende Nukleotidsequenzen New coding for the lipB gene nucleotide sequences |
| 03/14/2002 | DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit |
| 03/14/2002 | DE10041861A1 New nucleic acid that functions as caryposis-specific promoter, useful for tissue-selective gene expression or suppression in plants, also related transgenic plants |
| 03/14/2002 | DE10041541A1 New nucleic acid encoding moth allergens, related polypeptides and antibodies, useful in the diagnosis and treatment of arthropod allergies |
| 03/14/2002 | DE10041515A1 Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen Process for the production of ready, antigen-loaded or -unbeladener, cryopreserved mature dendritic cells |
| 03/14/2002 | CA2835978A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 03/14/2002 | CA2731495A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2431711A1 Remedies for heart failure |
| 03/14/2002 | CA2423247A1 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 03/14/2002 | CA2422649A1 Hydroxy-phenyl pyruvate dioxygenase fused with a signal peptide, dna sequence and use for obtaining plants containing herbicide-tolerant plants |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2422202A1 Modified carbon, silicon and germanium surfaces |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421911A1 Monocot seeds with increased lignan content |
| 03/14/2002 | CA2421858A1 Reporter system for cell surface receptor-ligand binding |
| 03/14/2002 | CA2421857A1 Method |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | CA2421840A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 03/14/2002 | CA2421834A1 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421760A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421757A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421584A1 Gene therapy for cardiac arrythmias |
| 03/14/2002 | CA2421489A1 Synthons for oligonucleotide synthesis |
| 03/14/2002 | CA2421448A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421445A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421409A1 Use of lipopeptides for immunotherapy of hiv-positive subjects |
| 03/14/2002 | CA2421391A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 03/14/2002 | CA2421386A1 Disease-resistant plants and method of constructing the same |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421374A1 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | CA2421324A1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 03/14/2002 | CA2421274A1 Method for down-regulating ige |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421265A1 Molecules for diagnostics and therapeutics |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | CA2421229A1 Vaccine against microbial pathogens |
| 03/14/2002 | CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421215A1 Genetic engineering of syringyl-enriched lignin in plants |
| 03/14/2002 | CA2421204A1 Method and system for detecting nucleic acids |
| 03/14/2002 | CA2421203A1 Method and system for identifying commercially distributed organisms |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |